应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
TERN Terns Pharmaceuticals, Inc.
交易中 02-13 13:12:11 EST
38.54
+0.79
+2.09%
最高
38.79
最低
37.37
成交量
30.17万
今开
37.78
昨收
37.75
日振幅
3.76%
总市值
42.01亿
流通市值
30.95亿
总股本
1.09亿
成交额
1,152万
换手率
0.38%
流通股本
8,032万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Leerink Partners 首次覆盖 Terns Pharmaceuticals，给予“跑赢大盘”评级，目标价58美元
美股速递 · 02-09
Leerink Partners 首次覆盖 Terns Pharmaceuticals，给予“跑赢大盘”评级，目标价58美元
Terns Pharmaceuticals需支付翰森制药1.0百万美元首付款及0.75%至1.25%分级销售提成
美股速递 · 01-23
Terns Pharmaceuticals需支付翰森制药1.0百万美元首付款及0.75%至1.25%分级销售提成
Terns Pharmaceuticals, Inc.盘中异动 大幅下挫5.00%报35.88美元
市场透视 · 01-10
Terns Pharmaceuticals, Inc.盘中异动 大幅下挫5.00%报35.88美元
Terns Pharmaceuticals, Inc.盘中异动 股价大跌5.00%
市场透视 · 01-09
Terns Pharmaceuticals, Inc.盘中异动 股价大跌5.00%
Terns Pharmaceuticals将在第44届摩根大通医疗健康年会公布2026年战略重点与研发里程碑
美股速递 · 01-08
Terns Pharmaceuticals将在第44届摩根大通医疗健康年会公布2026年战略重点与研发里程碑
新闻稿：Terns宣布拟进行公开募股
投资观察 · 2025-12-09
新闻稿：Terns宣布拟进行公开募股
Terns Pharmaceuticals第三季度净亏损2463.5万美元，优于IBES预期的2720万美元
投资观察 · 2025-11-20
Terns Pharmaceuticals第三季度净亏损2463.5万美元，优于IBES预期的2720万美元
Terns Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.48%
市场透视 · 2025-11-18
Terns Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.48%
Verrica制药盘中异动 早盘大幅下挫5.34%
市场透视 · 2025-11-04
Verrica制药盘中异动 早盘大幅下挫5.34%
Terns Pharmaceuticals飙升超80%，消息称其白血病疗法获得进展
老虎资讯综合 · 2025-11-03
Terns Pharmaceuticals飙升超80%，消息称其白血病疗法获得进展
Terns Pharmaceuticals, Inc.盘中异动 早盘急速跳水5.01%报8.16美元
市场透视 · 2025-10-29
Terns Pharmaceuticals, Inc.盘中异动 早盘急速跳水5.01%报8.16美元
Terns Pharmaceuticals 放弃口服 GLP-1，退出减重领域
Minhua笔记 · 2025-10-23
Terns Pharmaceuticals 放弃口服 GLP-1，退出减重领域
Terns Pharmaceuticals, Inc.股价重挫12.68% 市值跌7867.34万美元
市场透视 · 2025-10-22
Terns Pharmaceuticals, Inc.股价重挫12.68% 市值跌7867.34万美元
Terns Pharmaceuticals, Inc.: 两例参与者出现的无症状、可逆性3级肝酶升高被认定与药物相关
美股速递 · 2025-10-22
Terns Pharmaceuticals, Inc.: 两例参与者出现的无症状、可逆性3级肝酶升高被认定与药物相关
Terns Pharmaceuticals：三名参与者在治疗后随访期间出现无症状、可逆的3级肝酶升高
美股速递 · 2025-10-22
Terns Pharmaceuticals：三名参与者在治疗后随访期间出现无症状、可逆的3级肝酶升高
Terns Pharmaceuticals发布其评估口服GLP-1受体激动剂Tern-601治疗肥胖的第二阶段试验12周顶线数据
美股速递 · 2025-10-22
Terns Pharmaceuticals发布其评估口服GLP-1受体激动剂Tern-601治疗肥胖的第二阶段试验12周顶线数据
Terns Pharmaceuticals, Inc.盘中异动 大幅上涨5.01%报8.39美元
市场透视 · 2025-10-09
Terns Pharmaceuticals, Inc.盘中异动 大幅上涨5.01%报8.39美元
Terns Pharmaceuticals, Inc.盘中异动 快速上涨5.10%
市场透视 · 2025-10-06
Terns Pharmaceuticals, Inc.盘中异动 快速上涨5.10%
Terns Pharmaceuticals根据纳斯达克上市规则5635(C)(4)向新员工授予引导性股权
投资观察 · 2025-10-03
Terns Pharmaceuticals根据纳斯达克上市规则5635(C)(4)向新员工授予引导性股权
Terns Pharmaceuticals宣布根据纳斯达克上市规则5635(C)(4)向新员工提供引入性股权激励
美股速递 · 2025-10-03
Terns Pharmaceuticals宣布根据纳斯达克上市规则5635(C)(4)向新员工提供引入性股权激励
暂无数据
公司概况
公司名称：
Terns Pharmaceuticals, Inc.
所属市场：
NASDAQ
上市日期：
--
主营业务：
Terns Pharmaceuticals, Inc.于2016年12月9日根据开曼群岛法律注册成立。于2020年12月29日，该公司根据开曼群岛公司法（2020年修订）进行撤销注册及根据特拉华州普通公司法第388条进行归化（方式为向特拉华州州务卿提交归化证书），据此，其注册成立司法管辖权由开曼群岛变更为特拉华州，TernsPharmaceuticals Inc.是一家临床阶段的生物制药公司，开发一系列小分子候选产品，以应对严重疾病，包括肿瘤学和肥胖症。
发行价格：
--
{"stockData":{"symbol":"TERN","market":"US","secType":"STK","nameCN":"Terns Pharmaceuticals, Inc.","latestPrice":38.5375,"timestamp":1771006323625,"preClose":37.75,"halted":0,"volume":301728,"delay":0,"changeRate":0.02086092715231792,"floatShares":80316400,"shares":109000000,"eps":-1.031852,"marketStatus":"交易中","change":0.7875,"latestTime":"02-13 13:12:11 EST","open":37.78,"high":38.79,"low":37.37,"amount":11519118.735936001,"amplitude":0.037616,"askPrice":38.58,"askSize":208,"bidPrice":38.44,"bidSize":107,"shortable":3,"etf":0,"ttmEps":-1.031852,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771016400000},"marketStatusCode":2,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":37.75,"preHourTrading":{"tag":"盘前","latestPrice":37.44,"preClose":37.75,"latestTime":"09:29 EST","volume":454,"amount":16947.718758,"timestamp":1770992999999,"change":-0.31,"changeRate":-0.008212,"amplitude":0.014305},"postHourTrading":{"tag":"盘后","latestPrice":37.64,"preClose":37.75,"latestTime":"16:33 EST","volume":3134,"amount":118228.59,"timestamp":1770932006738,"change":-0.11,"changeRate":-0.002914,"amplitude":0.002914},"volumeRatio":0.338014,"impliedVol":0.6972,"impliedVolPercentile":0.3745},"requestUrl":"/m/hq/s/TERN/tweets","defaultTab":"tweets","newsList":[{"id":"1142952954","title":"Leerink Partners 首次覆盖 Terns Pharmaceuticals，给予“跑赢大盘”评级，目标价58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1142952954","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142952954?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:14","pubTimestamp":1770635674,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners宣布，首次将生物制药公司Terns Pharmaceuticals, Inc.纳入研究覆盖范围，并给予其“跑赢大盘”的评级。分析师为该股设定了58美元的目标股价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0889565916.HKD","TERN","BK4007","LU0320765992.SGD"],"gpt_icon":0},{"id":"1184499677","title":"Terns Pharmaceuticals需支付翰森制药1.0百万美元首付款及0.75%至1.25%分级销售提成","url":"https://stock-news.laohu8.com/highlight/detail?id=1184499677","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184499677?lang=zh_cn&edition=full","pubTime":"2026-01-23 05:13","pubTimestamp":1769116402,"startTime":"0","endTime":"0","summary":"Terns Pharmaceuticals, Inc.与翰森制药达成授权协议，根据协议条款，Terns Pharmaceuticals有义务向翰森制药支付一笔100万美元的一次性预付款。此外，协议还规定了基于年度净销售额的分级特许权使用费，费率在0.75%至1.25%之间浮动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0320765992.SGD","TERN","BK4007","LU0889565916.HKD"],"gpt_icon":0},{"id":"2602583637","title":"Terns Pharmaceuticals, Inc.盘中异动 大幅下挫5.00%报35.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602583637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602583637?lang=zh_cn&edition=full","pubTime":"2026-01-10 02:58","pubTimestamp":1767985107,"startTime":"0","endTime":"0","summary":"北京时间2026年01月10日02时58分，Terns Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.00%。截至发稿，该股报35.88美元/股，成交量141.053万股，换手率1.30%，振幅6.51%。Terns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Novabay Pharmaceuticals, Inc.、Cg Oncology, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aptevo Therapeutics Inc.、Pmgc Holdings Inc.、Ibio, Inc.较为活跃，换手率分别为643.48%、80.02%、49.29%，振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Akoustis Technologies Inc、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为53.49%、39.78%、35.11%。Terns Pharmaceuticals, Inc.公司简介：Terns Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110025827a4b16fac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110025827a4b16fac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TERN"],"gpt_icon":0},{"id":"2602397572","title":"Terns Pharmaceuticals, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602397572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602397572?lang=zh_cn&edition=full","pubTime":"2026-01-09 01:32","pubTimestamp":1767893547,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日01时32分，Terns Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.00%。截至发稿，该股报38.00美元/股，成交量110.188万股，换手率1.01%，振幅5.95%。Terns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，Enliven Therapeutics, Inc.、Century Therapeutics, Inc.、Moonlake Immunotherapeutics涨幅较大，Pmgc Holdings Inc.、Acrivon Therapeutics, Inc.、Gri Bio, Inc.较为活跃，换手率分别为501.85%、117.87%、71.98%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Enliven Therapeutics, Inc.、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为146.48%、59.43%、42.08%。Terns Pharmaceuticals, Inc.公司简介：Terns Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010901322797a14655&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010901322797a14655&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TERN"],"gpt_icon":0},{"id":"1193990811","title":"Terns Pharmaceuticals将在第44届摩根大通医疗健康年会公布2026年战略重点与研发里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1193990811","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193990811?lang=zh_cn&edition=full","pubTime":"2026-01-08 05:06","pubTimestamp":1767819981,"startTime":"0","endTime":"0","summary":"Terns Pharmaceuticals, Inc.将于第44届摩根大通医疗健康年会上，重点阐述公司面向2026年的核心发展战略及关键研发项目里程碑规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJLML261.HKD","LU1084165304.USD","IE0034235188.USD","LU0323591593.USD","LU1032466523.USD","LU0345770308.USD","IE00BLSP4452.SGD","LU2430703251.USD","LU0689472784.USD","LU0265550359.USD","IE00B775SV38.USD","LU1974910355.USD","IE00B3S45H60.SGD","LU2264538146.SGD","LU0256863811.USD","LU2211815571.USD","LU2237443549.SGD","LU0868494708.USD","LU1366192091.USD","LU0868494617.USD","LU1280957306.USD","LU1116320737.USD","LU1119994496.HKD","LU1145028129.USD","LU1261432733.SGD","LU0211327993.USD","LU2430703095.HKD","LU0238689110.USD","LU1064131342.USD","IE0034235303.USD","LU0070302665.USD","LU2756315664.SGD","LU0345770993.USD","IE00BBT3K403.USD","LU0345769128.USD","BK4550","LU2417539215.USD","IE00BYXW3230.USD","LU2023250504.SGD","LU1551013342.USD","LU2430703178.SGD","IE00B1BXHZ80.USD","LU0820561909.HKD","LU0208291251.USD","IE00B1XK9C88.USD","LU0048584097.USD","LU0106261372.USD","LU2756315318.SGD","LU1116320901.HKD","IE00BN8TJ469.HKD","LU1267930490.SGD","LU2592432038.USD","LU1548497426.USD","LU2237443978.SGD","LU2746668974.SGD","LU0170899867.USD","SG9999002224.SGD","LU1720051017.SGD","LU2023250843.SGD","LU2357305700.SGD","LU0964807845.USD","LU0820561818.USD","LU1496350502.SGD","IE00BLSP4239.USD","LU0251132253.USD","LU2106854487.HKD","BK4534","LU1244550577.SGD","LU2023250330.USD","LU0310799852.SGD","LU0640476718.USD","LU0211331839.USD","LU1629891620.HKD","BK4566","LU0943347566.SGD","BK4533","LU0971096721.USD","LU2213496289.HKD","BK4504","IE00BJTD4V19.USD","SG9999002232.USD","BK4207","LU0149725797.USD","IE00BJTD4N35.SGD","LU0211326839.USD","LU0320765646.SGD","IE00BKDWB100.SGD","LU2505996681.GBP","LU0417517546.SGD","LU1244550221.USD","LU0267386448.USD","LU0820562030.AUD","LU0211326755.USD","LU1363072403.SGD","IE000M9KFDE8.USD","IE00BDCRKT87.USD","BK4007","LU1917777945.USD","LU0215105999.USD","LU1668664300.SGD","LU2236285917.USD","IE00BZ1G4Q59.USD","LU2746668461.USD","LU2237443895.HKD","LU1914381329.SGD","LU0203347892.USD","LU2054465674.USD","LU2552382058.USD","TERN","LU0006306889.USD","BK4581","LU1720051108.HKD","LU0265550946.USD","LU2552382215.SGD","LU0106831901.USD","LU1988902786.USD","LU1670628061.USD","LU1670627923.USD","LU2381873111.SGD","LU2456880835.USD","LU2237443465.HKD","LU2505996509.AUD","LU2237443622.USD","BK4588","LU2237443382.USD","LU0683600562.USD","LU0942090050.USD","LU2462157665.USD","LU0345769631.USD","IE0034235295.USD","LU1244550494.USD","LU0787776722.HKD","LU1496350171.SGD","BK4516","IE00BKVL7J92.USD","LU2552382132.HKD","LU0203345920.USD","LU0320765489.SGD","IE00BDRTCR15.USD","LU0211328371.USD","LU0882574139.USD","LU1162221912.USD","BK4585","LU1551013425.SGD","IE00BWXC8680.SGD","LU0234572021.USD","LU0496365809.HKD","LU1894683264.USD","LU1894683348.USD","IE00BHPRN162.USD","LU2242649171.HKD","LU0976567544.SGD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"1126414242","title":"新闻稿：Terns宣布拟进行公开募股","url":"https://stock-news.laohu8.com/highlight/detail?id=1126414242","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126414242?lang=zh_cn&edition=full","pubTime":"2025-12-09 19:15","pubTimestamp":1765278930,"startTime":"0","endTime":"0","summary":"加利福尼亚州福斯特城，2025年12月9日-- Terns Pharmaceuticals, Inc.，一家处于临床阶段的肿瘤学公司，今日宣布已开始进行4亿美元普通股的承销公开募股，并向某些投资者提供购买普通股的预售认购权证。此外，Terns预计将授予承销商一个30天的选择权，可以根据公开募股价格额外购买最多6000万美元的普通股。所有将在此次募股中售出的普通股和预售认购权证均将由Terns提供。此次募股受市场及其他条件的影响，无法保证该募股是否及何时会完成，或其实际规模和条款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TERN","BK4007","USA"],"gpt_icon":0},{"id":"1192334801","title":"Terns Pharmaceuticals第三季度净亏损2463.5万美元，优于IBES预期的2720万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192334801","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192334801?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:17","pubTimestamp":1763572660,"startTime":"0","endTime":"0","summary":"11月10日——Terns Pharmaceuticals第三季度税前亏损为2465.89万美元，较IBES预期的2720万美元有所改善。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TERN"],"gpt_icon":0},{"id":"2584961613","title":"Terns Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584961613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584961613?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:39","pubTimestamp":1763476752,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时39分，Terns Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.48%。Terns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Olema Pharmaceuticals, Inc.、Can Fite Biopharma Ltd、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为1141.07%、653.11%、270.07%，振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd，振幅分别为57.86%、27.99%、27.62%。Terns Pharmaceuticals, Inc.公司简介：Terns Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111822391297715f29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111822391297715f29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TERN"],"gpt_icon":0},{"id":"2581274687","title":"Verrica制药盘中异动 早盘大幅下挫5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581274687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581274687?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:40","pubTimestamp":1762267201,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日22时40分，Verrica制药股票出现波动，股价大幅跳水5.34%。截至发稿，该股报3.37美元/股，成交量1.2852万股，换手率0.14%，振幅4.76%。Verrica制药股票所在的生物技术行业中，整体跌幅为0.69%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104224002a6e0b9e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104224002a6e0b9e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TERN","VRCA","BK4007"],"gpt_icon":0},{"id":"1125334279","title":"Terns Pharmaceuticals飙升超80%，消息称其白血病疗法获得进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1125334279","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125334279?lang=zh_cn&edition=full","pubTime":"2025-11-03 23:25","pubTimestamp":1762183528,"startTime":"0","endTime":"0","summary":"针对某类型白血病的疗法获得突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7e54b77236dde3dc9e8ebdf6ab786c86","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TERN"],"gpt_icon":0},{"id":"2579184273","title":"Terns Pharmaceuticals, Inc.盘中异动 早盘急速跳水5.01%报8.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579184273","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579184273?lang=zh_cn&edition=full","pubTime":"2025-10-29 21:49","pubTimestamp":1761745783,"startTime":"0","endTime":"0","summary":"北京时间2025年10月29日21时49分，Terns Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.01%。截至发稿，该股报8.16美元/股，成交量15.996万股，换手率0.18%，振幅4.13%。Terns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Purple Biotech Ltd、Surrozen Inc C/Wts 01/08/2031 、Ernexa Therapeutics Inc.涨幅较大，Purple Biotech Ltd、Ernexa Therapeutics Inc.、Aditxt, Inc.较为活跃，换手率分别为2313.32%、1030.27%、216.33%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Purple Biotech Ltd、Ernexa Therapeutics Inc.，振幅分别为132.00%、53.19%、38.39%。Terns Pharmaceuticals, Inc.公司简介：Terns Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102921494394e3d492&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102921494394e3d492&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TERN","BK4007"],"gpt_icon":0},{"id":"2577536959","title":"Terns Pharmaceuticals 放弃口服 GLP-1，退出减重领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2577536959","media":"Minhua笔记","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577536959?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:15","pubTimestamp":1761225354,"startTime":"0","endTime":"0","summary":"去年，Terns Pharmaceuticals 的口服减重药项目早期数据引起轰动，但其未能在一项中期研究中复制这一成功。该公司表示，由于安全性担忧和减重效果不佳，将终止 GLP-1 激动剂 TERN-601 的开发，并且没有计划推进或投资其他代谢疾病药物。受试者接受四种给药方案中的一种：每日一次、口服 TERN-601 或安慰剂。此外，11.9%的TERN-601治疗患者因不良事件而停止治疗。Danuglipron是辉瑞公司的口服GLP-1药物，但因肝脏安全性问题于今年早些时候停止开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023230353a6ca4eb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023230353a6ca4eb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GLP","TERN","BK4590","BK4144"],"gpt_icon":0},{"id":"2577722483","title":"Terns Pharmaceuticals, Inc.股价重挫12.68% 市值跌7867.34万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577722483","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577722483?lang=zh_cn&edition=full","pubTime":"2025-10-22 21:31","pubTimestamp":1761139901,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日21时31分，Terns Pharmaceuticals, Inc.股票出现异动，股价大幅跳水12.68%。Terns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Adaptimmune Therapeutics Plc、Rani Therapeutics Holdings, Inc.、Ethzilla Corporation C/Wts 06/11/2025涨幅较大，Rani Therapeutics Holdings, Inc.、Minerva Neurosciences, Inc、Arcturus Therapeutics Holdings Inc.较为活跃，换手率分别为28.14%、13.18%、10.13%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Rani Therapeutics Holdings, Inc.、Minerva Neurosciences, Inc，振幅分别为13.17%、10.53%、8.27%。Terns Pharmaceuticals, Inc.公司简介：Terns Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022213141a46ea96b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022213141a46ea96b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TERN"],"gpt_icon":0},{"id":"1194134113","title":"Terns Pharmaceuticals, Inc.: 两例参与者出现的无症状、可逆性3级肝酶升高被认定与药物相关","url":"https://stock-news.laohu8.com/highlight/detail?id=1194134113","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194134113?lang=zh_cn&edition=full","pubTime":"2025-10-22 04:09","pubTimestamp":1761077348,"startTime":"0","endTime":"0","summary":"Terns Pharmaceuticals, Inc.: 两例参与者出现的无症状、可逆性3级肝酶升高被认定与药物相关","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TERN"],"gpt_icon":0},{"id":"1176965124","title":"Terns Pharmaceuticals：三名参与者在治疗后随访期间出现无症状、可逆的3级肝酶升高","url":"https://stock-news.laohu8.com/highlight/detail?id=1176965124","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176965124?lang=zh_cn&edition=full","pubTime":"2025-10-22 04:07","pubTimestamp":1761077228,"startTime":"0","endTime":"0","summary":"Terns Pharmaceuticals：三名参与者在治疗后随访期间出现无症状、可逆的3级肝酶升高","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TERN","BK4007"],"gpt_icon":0},{"id":"1196901014","title":"Terns Pharmaceuticals发布其评估口服GLP-1受体激动剂Tern-601治疗肥胖的第二阶段试验12周顶线数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1196901014","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196901014?lang=zh_cn&edition=full","pubTime":"2025-10-22 04:06","pubTimestamp":1761077167,"startTime":"0","endTime":"0","summary":"Terns Pharmaceuticals发布其评估口服GLP-1受体激动剂Tern-601治疗肥胖的第二阶段试验12周顶线数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TERN"],"gpt_icon":0},{"id":"2574906184","title":"Terns Pharmaceuticals, Inc.盘中异动 大幅上涨5.01%报8.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574906184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574906184?lang=zh_cn&edition=full","pubTime":"2025-10-09 00:15","pubTimestamp":1759940124,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日00时15分，Terns Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.01%。Terns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。其相关个股中，Xenetic Biosciences, Inc.、Cingulate Inc C/Wts 10/12/2026 、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Xenetic Biosciences, Inc.、Acurx Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为2778.22%、1312.42%、848.15%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Xenetic Biosciences, Inc.、Adaptimmune Therapeutics Plc，振幅分别为107.47%、97.44%、64.07%。Terns Pharmaceuticals, Inc.公司简介：Terns Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510090015249723fe4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510090015249723fe4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TERN"],"gpt_icon":0},{"id":"2573689609","title":"Terns Pharmaceuticals, Inc.盘中异动 快速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573689609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573689609?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:32","pubTimestamp":1759757565,"startTime":"0","endTime":"0","summary":"北京时间2025年10月06日21时32分，Terns Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.10%。截至发稿，该股报8.65美元/股，成交量5.1171万股，换手率0.06%，振幅2.19%。Terns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Spruce Biosciences, Inc.、Leap Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Spruce Biosciences, Inc.、Palisade Bio, Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为1809.35%、65.60%、20.48%，振幅较大的相关个股有Spruce Biosciences, Inc.、Leap Therapeutics, Inc.、Reviva Pharmaceuticals Holdings, Inc.，振幅分别为53.97%、23.19%、9.98%。Terns Pharmaceuticals, Inc.公司简介：Terns Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006213245a4552acb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006213245a4552acb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TERN"],"gpt_icon":0},{"id":"1160731766","title":"Terns Pharmaceuticals根据纳斯达克上市规则5635(C)(4)向新员工授予引导性股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1160731766","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160731766?lang=zh_cn&edition=full","pubTime":"2025-10-03 04:07","pubTimestamp":1759435656,"startTime":"0","endTime":"0","summary":"加利福尼亚州福斯特城，2025年10月2日 -- Terns Pharmaceuticals, Inc.是一家临床阶段的生物制药公司，专注于开发小分子产品候选药物组合来治疗严重疾病，包括肿瘤学和肥胖症。公司今日宣布，截至2025年10月1日，已根据修订后的2022年就业引导奖励计划条款，向四名新员工授予股权引导奖励。这些股权奖励已获得公司董事会薪酬委员会批准，符合纳斯达克上市规则5635的规定，并作为吸引员工接受Terns工作邀请的重要激励措施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU0162691827.USD","LU0477156953.USD","BK4585","LU0106831901.USD","BK4007","BK4559","LU2417539215.USD","LU2125154935.USD","TERN","USJW.SI","LU1244550494.USD","TSYW.SI","LU1201861249.SGD","IE00BSNM7G36.USD","LU0130102774.USD","LU0130517989.USD","LU2462157665.USD","LU0310800965.SGD","BK4504","BK4534","LU1668664300.SGD","MNQmain","LU0170899867.USD","BK4207","NVIW.SI","USAW.SI","LU2456880835.USD","LU2360032135.SGD","NQmain","LU1267930227.SGD","LU1162221912.USD","LU1791807156.HKD","PSQ","TQQQ","QQQ","LU0128525689.USD",".IXIC","LU0098860793.USD","SQQQ","C","LU1244550577.SGD","LU0320765646.SGD","LU0072461881.USD","LU0052756011.USD","BK4588","LU0980610538.SGD","LU1244550221.USD","LU2125154778.USD","LU2236285917.USD","QID","LU0648001328.SGD","QLD","LU1366192091.USD"],"gpt_icon":1},{"id":"1111872096","title":"Terns Pharmaceuticals宣布根据纳斯达克上市规则5635(C)(4)向新员工提供引入性股权激励","url":"https://stock-news.laohu8.com/highlight/detail?id=1111872096","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111872096?lang=zh_cn&edition=full","pubTime":"2025-10-03 04:06","pubTimestamp":1759435601,"startTime":"0","endTime":"0","summary":"Terns Pharmaceuticals宣布根据纳斯达克上市规则5635(C)(4)向新员工提供引入性股权激励。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TERN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ternspharma.com","stockEarnings":[{"period":"1week","weight":0.0682},{"period":"1month","weight":0.0958},{"period":"3month","weight":0.6733},{"period":"6month","weight":4.3546},{"period":"1year","weight":7.6982},{"period":"ytd","weight":-0.0656}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.018},{"period":"3month","weight":0.0139},{"period":"6month","weight":0.0588},{"period":"1year","weight":0.1291},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Terns Pharmaceuticals, Inc.于2016年12月9日根据开曼群岛法律注册成立。于2020年12月29日，该公司根据开曼群岛公司法（2020年修订）进行撤销注册及根据特拉华州普通公司法第388条进行归化（方式为向特拉华州州务卿提交归化证书），据此，其注册成立司法管辖权由开曼群岛变更为特拉华州，TernsPharmaceuticals Inc.是一家临床阶段的生物制药公司，开发一系列小分子候选产品，以应对严重疾病，包括肿瘤学和肥胖症。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.15251},{"month":2,"riseRate":0.6,"avgChangeRate":-0.004421},{"month":3,"riseRate":0.2,"avgChangeRate":-0.064234},{"month":4,"riseRate":0.4,"avgChangeRate":-0.078723},{"month":5,"riseRate":0.4,"avgChangeRate":-0.039095},{"month":6,"riseRate":0.6,"avgChangeRate":0.061446},{"month":7,"riseRate":0.4,"avgChangeRate":-0.000641},{"month":8,"riseRate":0.6,"avgChangeRate":0.306524},{"month":9,"riseRate":0.6,"avgChangeRate":0.082474},{"month":10,"riseRate":0.6,"avgChangeRate":0.010604},{"month":11,"riseRate":0.4,"avgChangeRate":0.415594},{"month":12,"riseRate":0.6,"avgChangeRate":0.20601}],"exchange":"NASDAQ","name":"Terns Pharmaceuticals, Inc.","nameEN":"Terns Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Terns Pharmaceuticals, Inc.(TERN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Terns Pharmaceuticals, Inc.(TERN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Terns Pharmaceuticals, Inc.,TERN,Terns Pharmaceuticals, Inc.股票,Terns Pharmaceuticals, Inc.股票老虎,Terns Pharmaceuticals, Inc.股票老虎国际,Terns Pharmaceuticals, Inc.行情,Terns Pharmaceuticals, Inc.股票行情,Terns Pharmaceuticals, Inc.股价,Terns Pharmaceuticals, Inc.股市,Terns Pharmaceuticals, Inc.股票价格,Terns Pharmaceuticals, Inc.股票交易,Terns Pharmaceuticals, Inc.股票购买,Terns Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Terns Pharmaceuticals, Inc.(TERN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Terns Pharmaceuticals, Inc.(TERN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}